Field Cancerisation in Colorectal Cancer: a New Frontier or Pastures Past?

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2015 Apr 9

PMID 25852261

Citations 26

Authors

Abhilasha Patel

Gyanendra Tripathi

Kishore Gopalakrishnan

Nigel Williams

Ramesh P Arasaradnam

Affiliations

Soon will be listed here.

Abstract

Despite considerable advances in our understanding of cancer biology, early diagnosis of colorectal cancer remains elusive. Based on the adenoma-carcinoma sequence, cancer develops through the progressive accumulation of mutations in key genes that regulate cell growth. However, recent mathematical modelling suggests that some of these genetic events occur prior to the development of any discernible histological abnormality. Cells acquire pro-tumourigenic mutations that are not able to produce morphological change but predispose to cancer formation. These cells can grow to form large patches of mucosa from which a cancer arises. This process has been termed "field cancerisation". It has received little attention in the scientific literature until recently. Several studies have now demonstrated cellular, genetic and epigenetic alterations in the macroscopically normal mucosa of colorectal cancer patients. In some reports, these changes were effectively utilised to identify patients with a neoplastic lesion suggesting potential application in the clinical setting. In this article, we present the scientific evidence to support field cancerisation in colorectal cancer and discuss important limitations that require further investigation. Characterisation of the field defect is necessary to enable early diagnosis of colorectal cancer and identify molecular targets for chemoprevention. Field cancerisation offers a promising prospect for experimental cancer research and has potential to improve patient outcomes in the clinical setting.

Citing Articles

Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors.

Wierzbicki J, Bednarz-Misa I, Lewandowski L, Lipinski A, Klopot A, Neubauer K Int J Mol Sci. 2024; 25(3).

PMID: 38338661 PMC: 10855842. DOI: 10.3390/ijms25031383.

Exploring extracellular matrix and prostaglandin pathway alterations across varying resection margin distances of right-sided colonic adenocarcinoma.

Suwatthanarak T, Tanjak P, Suwatthanarak T, Acharayothin O, Thanormjit K, Chaiboonchoe A BMC Cancer. 2023; 23(1):1202.

PMID: 38062443 PMC: 10702019. DOI: 10.1186/s12885-023-11595-7.

Patterns of Gene Expression Profiles Associated with Colorectal Cancer in Colorectal Mucosa by Using Machine Learning Methods.

Ren J, Chen L, Guo W, Feng K, Cai Y, Huang T Comb Chem High Throughput Screen. 2023; 27(19):2921-2934.

PMID: 37957897 DOI: 10.2174/0113862073266300231026103844.

Associations Between Dog Breed and Clinical Features of Mammary Epithelial Neoplasia in Bitches: an Epidemiological Study of Submissions to a Single Diagnostic Pathology Centre Between 2008-2021.

Edmunds G, Beck S, Kale K, Spasic I, ONeill D, Brodbelt D J Mammary Gland Biol Neoplasia. 2023; 28(1):6.

PMID: 36961631 PMC: 10039094. DOI: 10.1007/s10911-023-09531-3.

Genome-wide analysis of mRNA and microRNA expression in colorectal cancer and adjacent normal mucosa.

Ito Y, Osakabe M, Niinuma T, Uesugi N, Sugimoto R, Yanagawa N J Pathol Clin Res. 2022; 8(4):313-326.

PMID: 35285580 PMC: 9161315. DOI: 10.1002/cjp2.268.

References

Bedi G, Westra W, Gabrielson E, Koch W, Sidransky D . Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996; 56(11):2484-7. View

Knudson Jr A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68(4):820-3. PMC: 389051. DOI: 10.1073/pnas.68.4.820. View

Tsao J, Yatabe Y, Salovaara R, Jarvinen H, Mecklin J, Aaltonen L . Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci U S A. 2000; 97(3):1236-41. PMC: 15581. DOI: 10.1073/pnas.97.3.1236. View

Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H . Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene. 2011; 31(3):342-51. DOI: 10.1038/onc.2011.241. View

Braakhuis B, Tabor M, Kummer J, Leemans C, Brakenhoff R . A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003; 63(8):1727-30. View

Roy H, Liu Y, Wali R, Kim Y, Kromine A, Goldberg M . Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis. Gastroenterology. 2004; 126(4):1071-81. DOI: 10.1053/j.gastro.2004.01.009. View

Hafner C, Toll A, Fernandez-Casado A, Earl J, Marques M, Acquadro F . Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci U S A. 2010; 107(48):20780-5. PMC: 2996414. DOI: 10.1073/pnas.1008365107. View

Kakizoe T . Development and progression of urothelial carcinoma. Cancer Sci. 2006; 97(9):821-8. PMC: 11159482. DOI: 10.1111/j.1349-7006.2006.00264.x. View

McCombs R, McCombs R . A HYPOTHESIS ON THE CAUSATION OF CANCER. Science. 1930; 72(1869):423-4. DOI: 10.1126/science.72.1869.423. View

10.

Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I . Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers. Gut. 2010; 59(11):1516-26. DOI: 10.1136/gut.2009.194787. View

11.

Riddell R, Levin B . Ultrastructure of the "transitional" mucosa adjacent to large bowel carcinoma. Cancer. 1977; 40(5 Suppl):2509-22. DOI: 10.1002/1097-0142(197711)40:5+<2509::aid-cncr2820400918>3.0.co;2-k. View

12.

Grady W, Parkin R, Mitchell P, Lee J, Kim Y, Tsuchiya K . Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene. 2008; 27(27):3880-8. DOI: 10.1038/onc.2008.10. View

13.

Dawson P, Habib N, Rees H, Wood C . Mucosal field change in colorectal cancer. Am J Surg. 1987; 153(3):281-4. DOI: 10.1016/0002-9610(87)90602-7. View

14.

Hanna-Morris A, Badvie S, Cohen P, McCullough T, Andreyev H, Allen-Mersh T . Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. J Clin Pathol. 2008; 62(4):325-30. DOI: 10.1136/jcp.2007.054643. View

15.

Bibbo M, Michelassi F, Bartels P, Dytch H, Bania C, Lerma E . Karyometric marker features in normal-appearing glands adjacent to human colonic adenocarcinoma. Cancer Res. 1990; 50(1):147-51. View

16.

Polley A, Mulholland F, Pin C, Williams E, Bradburn D, Mills S . Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006; 66(13):6553-62. DOI: 10.1158/0008-5472.CAN-06-0534. View

17.

Dakubo G, Jakupciak J, Birch-Machin M, Parr R . Clinical implications and utility of field cancerization. Cancer Cell Int. 2007; 7:2. PMC: 1838897. DOI: 10.1186/1475-2867-7-2. View

18.

Chen L, Hao C, Chiu Y, Wong P, Melnick J, Brotman M . Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res. 2004; 64(10):3694-700. DOI: 10.1158/0008-5472.CAN-03-3264. View

19.

Worthley D, Whitehall V, Buttenshaw R, Irahara N, Greco S, Ramsnes I . DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene. 2009; 29(11):1653-62. DOI: 10.1038/onc.2009.449. View

20.

Shen L, Kondo Y, Rosner G, Xiao L, Hernandez N, Vilaythong J . MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005; 97(18):1330-8. DOI: 10.1093/jnci/dji275. View